Caxton Associates (New York)’s Dr. Reddy's Laboratories RDY Stock Holding History

Caxton Associates (New York)’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-67,595	Closed	-$753K	–	715
2022 Q1	$753K	Buy	+67,595	New	+$766K	0.06%	153
2021 Q3	–	Sell	-14,915	Closed	-$219K	–	573
2021 Q2	$219K	Buy	+14,915	New	+$209K	0.02%	403
2014 Q1	–	Sell	-44,500	Closed	-$365K	–	243
2013 Q4	$365K	Buy	+44,500	New	+$352K	0.01%	198

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Caxton Associates (New York)'s RDY Position: Q2 2022 in Review

Caxton Associates (New York) sold out of Dr. Reddy's Laboratories (RDY) in Q2 2022, closing a stake of 67,595 shares — an estimated $753K sold.

Caxton Associates (New York) first reported a position in RDY in Q4 2013 and held it in 3 quarters. The position peaked at $753K in Q1 2022. 148 funds tracked by Wall St. Rank hold RDY as of Q2 2022.

Caxton Associates (New York) reported no remaining Dr. Reddy's Laboratories position as of Q2 2022 after selling out during the quarter.
Caxton Associates (New York) sold 67,595 Dr. Reddy's Laboratories shares in Q2 2022, an estimated $753K.
Caxton Associates (New York) first reported a position in Dr. Reddy's Laboratories in Q4 2013 and held it in 3 quarters.
Caxton Associates (New York)'s Dr. Reddy's Laboratories position peaked at $753K in Q1 2022.
148 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2022.

Based on Caxton Associates (New York)'s 13F filing for Q2 2022, filed 15 Aug 2022.